<DOC>
	<DOCNO>NCT02865928</DOCNO>
	<brief_summary>This randomize , double-blinded , placebo-controlled trial serratus plane block subject undergoing outpatient unilateral bilateral breast surgery . Ninety subject enrol study presurgical testing . Subjects stratify base surgery type randomize receive serratus plane block either bupivicaine HCL placebo . All patient receive standard intraoperative anesthesia standard postoperative pain control . The primary endpoint amount opioid administer postoperatively . Secondary endpoint include postoperative pain intensity time interval , amount opioid administer intraoperatively postoperatively , incidence nausea vomit , time discharge patient satisfaction</brief_summary>
	<brief_title>Serratus Plane Block Postoperative Pain Control</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>ASA IIII . Undergoing outpatient breast surgery require general anesthesia , include limited mastectomy , lumpectomy , reconstruction tissue expanders implant reconstruction revision . Unable provide inform consent . Patients pregnant nursing . ASA IVV . Alcohol narcotic dependence last 2 year . Concurrent condition require regular use analgesia may confound postsurgical assessment determine principle investigator . Hepatic disease . Allergies amide anesthetic determine medical history patient selfreport . Evidence infection injection site . Contraindication pain medication acetominophen , morphine , oxycodone , keterolac , dilaudid , Toradol . Body weight &lt; 50kg . BMI &gt; 40kg/m2 . History hypotension . Abnormal renal ( creatinine &gt; 1.5 mg/dL ) function . Heart block . Any physical , mental medical condition , opinion investigator , make study participation inadvisable .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>